Avanos Medical, Inc. ( AVNS) - Key Metrics
Stock symbol AVNS is outdated, potentially delisted? Maybe it is available on other exchange?
AVNS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $3.93 | $0.11 | -$0.27 | -$0.36 |
| 2025Q4 | $3.90 | $0.08 | $0.61 | $0.46 |
| 2025Q3 | $3.83 | -$0.03 | $0.30 | $0.15 |
| 2025Q2 | $3.80 | -$1.67 | $0.15 | -$0.09 |
| 2025Q1 | $3.63 | $0.14 | $0.56 | $0.41 |
AVNS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | 31.84 |
| 2025Q4 | 0% | 35.23 |
| 2025Q3 | 0% | -95.70 |
| 2025Q2 | 0% | -1.84 |
| 2025Q1 | 0% | 25.59 |
AVNS
Price: $24.99
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.60 USD
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 284800
Market Capitalization: 1.2 billion